Human Reproduction, Vol. 10, No. 4, pp. 911-918, 1995
© 1995 European Society of Human Reproduction and Embryology
research-article |
Implantation: Leukaemia inhibitory factor in human endometrium during the menstrual cycle: cellular origin and action on production of glandular epithelial cell prostaglandin in vitro
Center for Reproductive Medicine and Surgery, Department of Obstetrics and Gynecology, Baylor College of Medicine, One Baylor Plaza Houston, TX 77030, USA 1Department of Obstetrics and Gynecology, Hanyang University Hospital Seoul, 133-792, Korea
Correspondence: 2To whom correspondence should be addressed at: 6550 Fannin, Smith Tower Room 825, Houston, TX 77030, USA
Leukaemia inhibitory factor (LIF) is a pleiotrophic cytokine which plays an obligatory role in mouse implantation. To investigate its potential role in the regulation of uterine function in the human, LIF secretion by isolated human endometrial glandular epithelial and stromal cells in primary culture was determined. Endometrial cells secreted a detectable amount of LIF protein during the first 48 h of culture. In the follicular and late-luteal phases, LIF secretion by both cell types was low. At every stage of the menstrual cycle, the epithelial cells secreted significantly more LIF than did stromal cells. Glandular epithelial cells of the mid-luteal phase, at the expected time of implantation in the human, secreted significantly more LIF than at other stages of the cycle. Stromal cells showed a similar, but nonsignificant, LIF secretion pattern. It could be concluded that endometrial LIF expression was dependent on cell type and stage of the menstrual cycle, and might thus play a role in human implantation. Oestradiol-17
stimulated both prostaglandin (PG) F and E release by the epithelial cells in both follicular and luteal phases. PGE release during the luteal phase was greater than in the follicular phase. However, addition of recombinant human LIF did not change either PGF or PGE release in either follicular or luteal phases, in the presence or absence of oestradiol.
Key words: endometrium/human/in vitro/leukaemia inhibitory factor/prostaglandin
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. J Kimber Leukaemia inhibitory factor in implantation and uterine biology Reproduction, August 1, 2005; 130(2): 131 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Horcajadas, A. Riesewijk, J. Polman, R. van Os, A. Pellicer, S. Mosselman, and C. Simon Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles Mol. Hum. Reprod., March 1, 2005; 11(3): 195 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Gonzalez, B. R. Rueda, M. P. Ramos, R. D. Littell, S. Glasser, and P. C. Leavis Leptin-Induced Increase in Leukemia Inhibitory Factor and Its Receptor by Human Endometrium Is Partially Mediated by Interleukin 1 Receptor Signaling Endocrinology, August 1, 2004; 145(8): 3850 - 3857. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Mitchell, R. J. Swanson, and S. Oehninger In Vivo Effect of Leukemia Inhibitory Factor (LIF) and an Anti-LIF Polyclonal Antibody on Murine Embryo and Fetal Development Following Exposure at the Time of Transcervical Blastocyst Transfer Biol Reprod, August 1, 2002; 67(2): 460 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ledee-Bataille, G. Lapree-Delage, J.-L. Taupin, S. Dubanchet, R. Frydman, and G. Chaouat Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation Hum. Reprod., January 1, 2002; 17(1): 213 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-P. Yue, Z.-M. Yang, P. Wei, S.-J. Li, H.-B. Wang, J.-H. Tan, and M. J.K. Harper Leukemia Inhibitory Factor, Leukemia Inhibitory Factor Receptor, and Glycoprotein 130 in Rhesus Monkey Uterus During Menstrual Cycle and Early Pregnancy Biol Reprod, August 1, 2000; 63(2): 508 - 512. [Abstract] [Full Text] |
||||
![]() |
C. J. Auernhammer and S. Melmed Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function Endocr. Rev., June 1, 2000; 21(3): 313 - 345. [Abstract] [Full Text] |
||||
![]() |
S.M. Laird, E.M. Tuckerman, B.A. Cork, and T.C. Li Expression of nuclear factor {kappa} B in human endometrium; role in the control of interleukin 6 and leukaemia inhibitory factor production Mol. Hum. Reprod., January 1, 2000; 6(1): 34 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Knight, C. P. Lydell, D. Zhou, T. D. Weir, R. Robert Schellenberg, and T. R. Bai Leukemia Inhibitory Factor (LIF) and LIF Receptor in Human Lung . Distribution and Regulation of LIF Release Am. J. Respir. Cell Mol. Biol., April 1, 1999; 20(4): 834 - 841. [Abstract] [Full Text] |
||||
![]() |
D. J. Hirzel, J. Wang, S.K. Das, S.K. Dey, and R.A. Mead Changes in Uterine Expression of Leukemia Inhibitory Factor during Pregnancy in the Western Spotted Skunk Biol Reprod, February 1, 1999; 60(2): 484 - 492. [Abstract] [Full Text] [PDF] |
||||






